What does Aa.Pharma Turnhout do?

Aa.Pharma Turnhout is a logistics company in Turnhout. Public Limited, started on 14 November 1988, 1 establishment.

What is the address of Aa.Pharma Turnhout?

The registered office of Aa.Pharma Turnhout is located at Steenweg op Oosthoven 126 box 1, 2300 Turnhout.

Is Aa.Pharma Turnhout still active?

Yes. According to the CBE (29 October 2026) Aa.Pharma Turnhout is active, legal situation “Normale toestand”, started on 14 November 1988.

Is Aa.Pharma Turnhout registered on Peppol?

Yes, Aa.Pharma Turnhout is registered on the Peppol network with ID 0208:0435762503.

What is the enterprise number of Aa.Pharma Turnhout?

The enterprise number of Aa.Pharma Turnhout is BE0435762503.

When was Aa.Pharma Turnhout founded?

Aa.Pharma Turnhout was founded on 14 November 1988.

Who are the directors of Aa.Pharma Turnhout?

According to the 2025 annual accounts, the directors of Aa.Pharma Turnhout are: Annelies Robrechts, Ruth Smits, Diederik Stas.

Is Aa.Pharma Turnhout a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 14 November 1988; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did Aa.Pharma Turnhout make in 2025?

Aa.Pharma Turnhout posted a profit after taxes of € 106,725 in financial year 2025.

What is the revenue of Aa.Pharma Turnhout?

As a small company, Aa.Pharma Turnhout is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 528,562.

How much does an employee at Aa.Pharma Turnhout earn?

The average wage cost per full-time employee at Aa.Pharma Turnhout was € 81,600 in 2025: staff costs of € 293,666 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Aa.Pharma Turnhout have?

According to the 2025 annual accounts, Aa.Pharma Turnhout has 3.6 full-time equivalents (FTE).

Does Aa.Pharma Turnhout have a website?

Yes, Aa.Pharma Turnhout has a website at aapharma.be.

Aa.Pharma Turnhout (Public Limited) - Turnhout

Dossier Aa.Pharma Turnhout, printed on 29 October 2026 from databakkes.be/en/0435762503/aa-pharma-turnhout. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Aa.Pharma Turnhout from Turnhout, company number BE0435762503, closed financial year 2025 with a result of € 106,725 after tax. For that financial year Aa.Pharma Turnhout recorded a gross margin of € 528,562 and equity of € 177,231. Compared with financial year 2024, the result moved from € 80,591 to € 106,725. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 6, 2026.

What it is worth Healthy

€ 177,231

▼ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 106,725

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 115,297

▲ 15% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 111,065 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

3.6

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 293,666

▲ 2% vs 2024

€ 81,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 4,083

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 406,386

▼ 29% vs 2024

€ 79,788 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 217,789

▲ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 43,838

▲ 24% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 512,529 Gross margin 2022: € 512,529 First fiscal year in the series	€ 478,343 Gross margin 2023: € 478,343 ▼ 7% vs 2022 (€ 512,529) Unfavourable step	€ 490,857 Gross margin 2024: € 490,857 ▲ 3% vs 2023 (€ 478,343) Favourable step	€ 528,562 Gross margin 2025: € 528,562 ▲ 8% vs 2024 (€ 490,857) Favourable step	▲ 8%
Profit after taxes	€ 91,153 Profit after taxes 2022: € 91,153 First fiscal year in the series	€ 75,370 Profit after taxes 2023: € 75,370 ▼ 17% vs 2022 (€ 91,153) Unfavourable step	€ 80,591 Profit after taxes 2024: € 80,591 ▲ 7% vs 2023 (€ 75,370) Favourable step	€ 106,725 Profit after taxes 2025: € 106,725 ▲ 32% vs 2024 (€ 80,591) Favourable step	▲ 32%
Equity	€ 190,252 Equity 2022: € 190,252 First fiscal year in the series	€ 185,912 Equity 2023: € 185,912 ▼ 2% vs 2022 (€ 190,252) Unfavourable step	€ 181,571 Equity 2024: € 181,571 ▼ 2% vs 2023 (€ 185,912) Unfavourable step	€ 177,231 Equity 2025: € 177,231 ▼ 2% vs 2024 (€ 181,571) Unfavourable step	▼ 2%
Total debts	€ 1,336,653 Total debts 2022: € 1,336,653 First fiscal year in the series	€ 1,092,057 Total debts 2023: € 1,092,057 ▼ 18% vs 2022 (€ 1,336,653) Favourable step	€ 1,013,349 Total debts 2024: € 1,013,349 ▼ 7% vs 2023 (€ 1,092,057) Favourable step	€ 1,004,719 Total debts 2025: € 1,004,719 ▼ 1% vs 2024 (€ 1,013,349) Favourable step	▼ 1%
Cash	€ 102,558 Cash 2022: € 102,558 First fiscal year in the series	€ 126,737 Cash 2023: € 126,737 ▲ 24% vs 2022 (€ 102,558) Favourable step	€ 100,298 Cash 2024: € 100,298 ▼ 21% vs 2023 (€ 126,737) Unfavourable step	€ 115,297 Cash 2025: € 115,297 ▲ 15% vs 2024 (€ 100,298) Favourable step	▲ 15%
Land & buildings	€ 669,546 Land & buildings 2022: € 669,546 First fiscal year in the series	€ 674,724 Land & buildings 2023: € 674,724 ▲ 1% vs 2022 (€ 669,546) Unchanged	€ 645,647 Land & buildings 2024: € 645,647 ▼ 4% vs 2023 (€ 674,724) Unchanged	€ 614,889 Land & buildings 2025: € 614,889 ▼ 5% vs 2024 (€ 645,647) Unchanged	▼ 5%
Retained profit	€ 117,772 Retained profit 2022: € 117,772 First fiscal year in the series	€ 113,432 Retained profit 2023: € 113,432 ▼ 4% vs 2022 (€ 117,772) Unfavourable step	€ 109,091 Retained profit 2024: € 109,091 ▼ 4% vs 2023 (€ 113,432) Unfavourable step	€ 104,751 Retained profit 2025: € 104,751 ▼ 4% vs 2024 (€ 109,091) Unfavourable step	▼ 4%
Dividend	€ 412,500 Dividend 2022: € 412,500 First fiscal year in the series	€ 79,710 Dividend 2023: € 79,710 ▼ 81% vs 2022 (€ 412,500) Unchanged	€ 84,931 Dividend 2024: € 84,931 ▲ 7% vs 2023 (€ 79,710) Unchanged	€ 111,065 Dividend 2025: € 111,065 ▲ 31% vs 2024 (€ 84,931) Unchanged	▲ 31%
Bank debt	€ 683,643 Bank debt 2022: € 683,643 First fiscal year in the series	€ 725,121 Bank debt 2023: € 725,121 ▲ 6% vs 2022 (€ 683,643) Unfavourable step	€ 569,684 Bank debt 2024: € 569,684 ▼ 21% vs 2023 (€ 725,121) Favourable step	€ 406,386 Bank debt 2025: € 406,386 ▼ 29% vs 2024 (€ 569,684) Favourable step	▼ 29%
Balance sheet total	€ 1,565,644 Balance sheet total 2022: € 1,565,644 First fiscal year in the series	€ 1,314,473 Balance sheet total 2023: € 1,314,473 ▼ 16% vs 2022 (€ 1,565,644) Unchanged	€ 1,229,189 Balance sheet total 2024: € 1,229,189 ▼ 6% vs 2023 (€ 1,314,473) Unchanged	€ 1,213,984 Balance sheet total 2025: € 1,213,984 ▼ 1% vs 2024 (€ 1,229,189) Unchanged	▼ 1%
Employees (FTE)	4.6 Employees (FTE) 2022: 4.6 First fiscal year in the series	3.7 Employees (FTE) 2023: 3.7 ▼ 0.9 vs 2022 (4.6) Unchanged	3.6 Employees (FTE) 2024: 3.6 ▼ 0.1 vs 2023 (3.7) Unchanged	3.6 Employees (FTE) 2025: 3.6 Unchanged (3.6) Unchanged

Key figures of Aa.Pharma Turnhout, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Aa.Pharma Turnhout?

What happened at Aa.Pharma Turnhout in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Annelies Robrechts stepped down as director. NBB
2026 Ruth Smits stepped down as director. NBB
2026 Diederik Stas stepped down as director. NBB
May 6, 2026 New annual accounts for financial year 2025: profit of € 106,725 (▲ 32% vs 2024). Source: NBB ↗
2020 Annelies Robrechts became a director. NBB
2020 Ruth Smits became a director. NBB
2020 Diederik Stas became a director. NBB
Dec 1, 1988 New establishment in Turnhout. KBO

In short

From € 91,153 profit in 2022 to € 106,725 profit in 2025.

Paid € 112,431 in corporate taxes since 2022.

Best year ever: 2025, with € 106,725 profit.

On average € 146,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PROSANA 100%

The stake of PROSANA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Aa.Pharma Turnhout

The shares are held by PROSANA (100%).

Directors

According to the 2025 annual accounts

Annelies Robrechts

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Oosthoven, JacoRob, PROSANA

since 2020 · until 2026

Ruth Smits

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Oosthoven, ARUCAREA, PROSANA

since 2020 · until 2026

Diederik Stas

Director

Also active at: Aa.Pharma Oud-Turnhout, Aa.Pharma Oosthoven, PROSANA

since 2020 · until 2026

Shareholders

PROSANA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg op Oosthoven 126 box 1

2300 Turnhout

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Vereniging van mede-eigenaars Residentie "Quercus Ilex" appartementsgebouw te 2300 Turnhout , Steenweg op Oosthoven 126

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS aapharma.be

Technologies

ASP.NETApacheElementorGoogle AnalyticsGoogle Tag ManagerPHPSwiperWordPressYoast SEOjQueryjQuery UIlazysizes

Hosting & Email

Email provider

Microsoft 365

Hosting

TUXIS, NL

Website info

HTTPS Ja

Languages NL

Features

Webshop Blog Jobs Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0435.762.503

VAT number

BE 0435.762.503

Registered office

Steenweg op Oosthoven 126 bus 1, 2300 Turnhout

Names & denominations

Aa.Pharma Turnhout

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

14 November 1988

Peppol

Active · Active since 19 Aug 2025

Contact

aapharma.be

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Aa.Pharma Turnhout

Warning lights

Financials

What happened to Aa.Pharma Turnhout?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions